← All stories
Markets
Are Patent Expiration Cycles & Biosimilar — The Next Catalyst to Watch
Highlights Patent expirations eliminate pricing power on established medicines, forcing healthcare companies to transition to newly approved products or face revenue declines and margin compression as biosimilar competitors capture market s…
Covered by 1 outlet
All coverage · 1 article